Current controversies regarding the cardiovascular effects of hormone therapy

被引：13

作者：

Karas, RH ^{[1
]}

机构：

[1] Tufts Univ New England Med Ctr, Dept Med, Div Cardiol, Mol Cardiol Res Inst, Boston, MA 02111 USA

来源：

CLINICAL OBSTETRICS AND GYNECOLOGY | 2004年 / 47卷 / 02期

关键词：

D O I：

10.1097/00003081-200406000-00024

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

[No abstract available]

引用

页码：489 / 499

页数：11

共 23 条

[1] Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen [J].

Chen, Z ;

Yuhanna, IS ;

Galcheva-Gargova, Z ;

Karas, RH ;

Mendelsohn, RE ;

Shaul, PW .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (03) :401-406

[2]

Clarkson TB, 1998, J REPROD MED, V43, P741

[3] Cardiovascular disease outcomes during 6.8 years of hormone therapy - Heart and Estrogen/progestin Replacement Study follow-up (HERS II) [J].

Grady, D ;

Herrington, D ;

Bittner, V ;

Blumenthal, R ;

Davidson, M ;

Hlatky, M ;

Hsia, J ;

Hulley, S ;

Herd, A ;

Khan, S ;

Newby, LK ;

Waters, D ;

Vittinghoff, E ;

Wenger, N .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (01) :49-57

[4] HORMONE-THERAPY TO PREVENT DISEASE AND PROLONG LIFE IN POSTMENOPAUSAL WOMEN [J].

GRADY, D ;

RUBIN, SM ;

PETITTI, DB ;

FOX, CS ;

BLACK, D ;

ETTINGER, B ;

ERNSTER, VL ;

CUMMINGS, SR .

ANNALS OF INTERNAL MEDICINE, 1992, 117 (12) :1016-1037

[5] Postmenopausal estrogen and progestin use and the risk of cardiovascular disease [J].

Grodstein, F ;

Stampfer, MJ ;

Manson, JE ;

Colditz, GA ;

Willett, WC ;

Rosner, B ;

Speizer, FE ;

Hennekens, CH .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (07) :453-461

[6] Effects of estrogen replacement on the progression of coronary-artery atherosclerosis [J].

Herrington, DM ;

Reboussin, DM ;

Brosnihan, KB ;

Sharp, PC ;

Shumaker, SA ;

Snyder, TE ;

Furberg, CD ;

Kowalchuk, GJ ;

Stuckey, TD ;

Rogers, WJ ;

Givens, DH ;

Waters, D .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (08) :522-529

[7] Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women [J].

Hodis, HN ;

Mack, WJ ;

Azen, SP ;

Lobo, RA ;

Shoupe, D ;

Mahrer, PR ;

Faxon, DP ;

Cashin-Hemphill, L ;

Sanmarco, ME ;

French, WJ ;

Shook, TL ;

Gaarder, TD ;

Mehra, AO ;

Rabbani, R ;

Sevanian, A ;

Shil, AB ;

Torres, M ;

Vogelbach, KH ;

Selzer, RH ;

Hodis, HN ;

Azen, SP ;

Faxon, DP ;

Lobo, RA ;

Mack, WJ ;

Charlson, M ;

Gesselman, C ;

Morales, T ;

Torres, M ;

Watcher, F ;

Zurbrugg, L ;

Faxon, DP ;

Mehra, AO ;

Rabbani, R ;

Agra, B ;

Coria, I ;

Ee, J ;

Johnson, S ;

Reyes, L ;

Stolicky, C ;

Mahrer, PR ;

Aharonian, VJ ;

Browning, RA ;

Jackimowicz, P ;

Scutella, PJ ;

Velasco, A ;

Williams, C ;

French, WJ ;

Shook, TL ;

Matthews, RV ;

Vogelbach, KH .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (06) :535-545

[8] Estrogen in the prevention of atherosclerosis - A randomized, double-blind, placebo-controlled trial [J].

Hodis, HN ;

Mack, WJ ;

Lobo, RA ;

Shoupe, D ;

Sevanian, A ;

Mahrer, PR ;

Selzer, RH ;

Liu, CR ;

Liu, CH ;

Azen, SP .

ANNALS OF INTERNAL MEDICINE, 2001, 135 (11) :939-953

[9] Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women [J].

Hulley, S ;

Grady, D ;

Bush, T ;

Furberg, C ;

Herrington, D ;

Riggs, B ;

Vittinghoff, E .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (07) :605-613

[10]

Karas R, 2003, MENOPAUSAL MED, V10, P8

← 1 2 3 →